Recent news on Sabril

Study Of Investigational Drug To Treat Cocaine And Methamphetamine ...  -  May 9, 2007
eMaxHealth.com,These data potentially provide a basis for linking CPP-109 to the extensive body of published pre-clinical and clinical literature on Sabril.

Catalyst Pharmaceutical Partners Reports Year-End 2006 Financial ...  -  Apr 3, 2007
PharmaLive.com (press release),...trial quantities of CPP-109 and commenced a study to demonstrate that CPP-109 is bioequivalent to "Sabril" (registered trademark of Sanofi-Aventis),

Ovation hopes to reduce addictions  -  Feb 12, 2007
Chicago Sun-Times,Ovation already sells the drug under the brand name Sabril in Canada and Mexico to treat epilepsy. Ovation, which employs roughly 200 people, is on track to

Catalyst focuses on drug to treat addicts  -  Jan 14, 2007
Miami Herald,Under the brand name Sabril, it is now sold by a Belgium firm in more than 60 countries, but not the United States. The problem is that long-time usage of

Catalyst Pharmaceutical Partners Provides An Update On Its ...  -  Jan 5, 2007
Medical News Today (press release),...the Company intends to perform the studies required to demonstrate that CPP-109 is bioequivalent to "Sabril" (registered trademark of Sanofi-Aventis),

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional